Join the DDA or

October supply issues update

Ongoing supply problems listed

November 5th 2018

Tagged: Clinical guidance news Dispensary guidance news

By Ailsa Colquhoun

The Department of Health and Social Care has published its October medicines supply issues update This details the following shortages:

Epilim 250mg chromosphere: no stock available until the end of November.  Stock levels of 100mg and 500mg Epilim Chronosphere are sufficient only for normal market demand. Alternatives include: Epilim Liquid and Epilim Syrup, and other sodium valproate preparations

Fragmin (dalteparin) 2,500units/ 5,000units and 7,500units (Pfizer).


  •  2,500units presentation – out of stock with a resupply date of w/c 12 November
  • 5,000 units presentation – likely to go out of stock during w/c 31 October with a resupply date of w/c 12 November.
  • 7,500units presentation –  out of stock with a resupply date of w/c 12 November
  • Alternative LMWH suppliers are available.

Stemetil (prochloperazine) 5mg in 5ml oral syrup: very limited stock available until approximately late November 2018 with next delivery not due until the middle of 2019.

Salofalk (mesalazine) 500mg suppositories (Dr. Falk Pharma).

  • Supplies are currently limited and there is likely to be a two-week gap in supply until the next delivery of stock in late November.
  • A very small amount of stock will be reserved for emergency orders
  • Salofalk 1g suppositories will remain available.

The letter also details ongoing and resolved issues, and discontinuations.

For all the latest news of the 2018 DDA annual conference...

Learn more